Results from the phase 3 RECITE trial show that romiplostim significantly reduces chemotherapy-induced thrombocytopenia, ...

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...

New findings from the phase III PRIMARY2 trial presented at EAU26 suggest that PSMA PET/CT imaging after inconclusive or reassuring MRI can safely reduce prostate biopsies by about 50 percent without ...

A nationwide U.S. study published in JAMA, analyzing data from 2.15 million women with breast cancer, found that choosing complementary and alternative medicine (CAM) instead of evidence-based therapy ...

Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. They not only infect and kill cancer cells, but also modulate the tumor micro-environment to enhance ...

The FDA has approved the first-of-its-kind mixed-reality system, HipInsight® 2.0, enhancing hip arthroplasty with 3D visualizations and patient-specific models. This technology projects surgical plans ...

Longer-term follow-up from the Phase 1b/2 OrigAMI-1 study shows that amivantamab (Rybrevant) plus FOLFOX or FOLFIRI achieved a 51% overall response rate in RAS/BRAF wild-type metastatic colorectal ...

BioNTech SE and Bristol Myers Squibb have partnered to co-develop and co-commercialize BNT327, a next-generation bispecific antibody targeting PD-L1 and VEGF-A in over 10 solid tumor indications. The ...

Despite two decades of clinical experience with Everolimus in transplant medicine, cancer patients continue to face preventable toxicities and fatal adverse events. While transplant patients benefit ...

A new PNAS study unveils a hidden vulnerability of prostate cancer: the protein-disulfide isomerases PDIA1 and PDIA5, which stabilize androgen receptor and sustain tumor survival. Inhibition of these ...

ConcertAI and Caris Life Sciences have formed a strategic partnership with AbbVie to accelerate oncology research and clinical trials. Utilizing AI and ML, they will leverage extensive clinical and ...